MedTech Innovator

MedTech Innovator is a nonprofit global competition and accelerator based in Los Angeles, California, founded in 2013. It focuses on supporting companies in the medical device, digital health, and diagnostic sectors. The organization aims to enhance patient outcomes by fostering the growth of businesses that contribute to the transformation of the healthcare system. Each year, MedTech Innovator showcases 100 companies that align with key themes identified through surveys of industry leaders. The accelerator's diverse portfolio includes firms involved in consumer healthcare, imaging, remote patient monitoring, clinical studies, and workflow optimization, emphasizing its commitment to advancing innovative healthcare solutions.

Paul Grand

CEO

Ayelet Marom Ph.D

Vice President, Programs

Past deals in Technology

TrackX

Non Equity Assistance in 2022
TrackX Technology develops a tracking technology that provides real-time virtual live fluoroscopy. It focuses on creating profound procedurally driven imaging solutions that provide priceless benefits to the surgeon, hospital, and entire operating room.

Phiex Technologies

Non Equity Assistance in 2022
Phiex Technologies on-demand, interactive materials for efficient and cost-effective medical device manufacturing, food safety and packaging, and innovations for pathogens.

Leadoptik

Non Equity Assistance in 2022
Leadoptik is a California-based company operating in stealth mode, focused on developing advanced miniature imaging technology for minimally invasive medical procedures. This innovative technology enhances surgeons' ability to view small objects with improved clarity compared to existing imaging systems, offering 3D navigation capabilities and high-resolution imaging. By facilitating the early detection of cancer in patients, Leadoptik aims to significantly improve surgical outcomes and patient care.

AltraTech

Seed Round in 2019
AltraTech Limited, established in 2013 and located in Shannon, Ireland, specializes in the design of biosensors and semiconductor chips aimed at DNA testing for food traceability in the agricultural sector. The company has developed a portable device that enhances molecular detection of viral DNA and RNA using advanced enrichment and semiconductor techniques. This innovation achieves the sensitivity and specificity comparable to traditional PCR methods, allowing for rapid and accurate measurement of viral samples. Through these technologies, AltraTech contributes to improving food safety and quality in the agri-business industry.

toSense

Seed Round in 2019
toSense is focused on rapidly bringing devices to the market that address real-world medical issues. toSense’s solutions include both hardware (custom sensors) and software (servers), along with wireless solutions (gateways) that connect these components. Our core focus is the CoVa Sensor and its unique hardware and algorithms. Third-party software systems can integrate with this novel component using our gateways and web services.
Advanced Chemotherapy Technologies is a healthcare company that is developing breakthrough combination drug-device technologies for treating pancreatic cancer.

2C Tech

Grant in 2014
2C Tech Corporation, based in Irvine, California, is a biotech company specializing in the development of medical devices that utilize nanotechnology for ophthalmic applications. The company's flagship product, SeeQ, employs intraocularly delivered photoactive nanoparticles to convert light into electrical energy, functioning similarly to a solar cell. 2C Tech is dedicated to creating innovative therapies for retinal degenerative conditions, particularly focusing on Retinitis Pigmentosa, a disease for which there are currently no effective treatments. The company's research also aims to address other serious eye conditions, including certain forms of Macular Degeneration, Glaucoma, and Diabetic Retinopathy, which affect larger patient populations. By leveraging its expertise in nanoparticle technologies, 2C Tech seeks to provide meaningful therapeutic benefits for those suffering from these debilitating diseases.

NeuroTronik

Grant in 2014
NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.